Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
Recruiting · NCT06992440 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 2 | 2026-08-13 | NCT06992440 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gustavo A Heresi, MD, MS | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| The Cleveland Clinic | 239 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic | Cleveland | United States | 558 |
| The Johns Hopkins Hospital | Baltimore | United States | 26 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |